| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/34186311_HAS_TOPIC_C0006104> <https://research.tib.eu/covid-19/entity/34186311_HAS_TOPIC_C0021368> <https://research.tib.eu/covid-19/entity/34186311_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/34186311_HAS_TOPIC_C5200801> <https://research.tib.eu/covid-19/entity/34186311_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/34186311_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/34186311_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'D\'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil.\', \'National Institute for Science and Technology on Neuroimmunomodulation (INCT/NIM), Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil; Laboratory on Thymus Research, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.\', \'D\'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil; Institute of Biomedical Sciences, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.\', \'Institute of Biomedical Sciences, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.\', \'Immunopharmacology Laboratory, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil; National Institute for Science and Technology on Innovation in Diseases of Neglected Populations (INCT/IDPN), Center for Technological Development in Health (CDTS), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.\', \'Immunopharmacology Laboratory, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil; Program of Immunology and Inflammation, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.\', \'Immunopharmacology Laboratory, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.\', \'D\'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil; Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.\', \'Pluricell Biotech, São Paulo, SP, Brazil.\', \'Pluricell Biotech, São Paulo, SP, Brazil; Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.\', \'National Institute for Science and Technology on Innovation in Diseases of Neglected Populations (INCT/IDPN), Center for Technological Development in Health (CDTS), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.\', \'D\'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil; Institute of Biomedical Sciences, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil; Institute of Biology, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil. Electronic address: srehen@lance-ufrj.org.\', \'National Institute for Science and Technology on Innovation in Diseases of Neglected Populations (INCT/IDPN), Center for Technological Development in Health (CDTS), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil; Program of Immunology and Inflammation, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil. Electronic address: tmoreno@cdts.fiocruz.br.\', \'D\'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil; Institute of Biomedical Sciences, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil. Electronic address: marilia@lance-ufrj.org.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Arag%C3%A3o_Luiz_G_H_S> <https://research.tib.eu/covid-19/entity/Biagi_Diogo> <https://research.tib.eu/covid-19/entity/Borges_Helena_L> <https://research.tib.eu/covid-19/entity/Bozza_Patr%C3%ADcia_T> <https://research.tib.eu/covid-19/entity/Cardoso_Soares_Vinicius> <https://research.tib.eu/covid-19/entity/Cruvinel_Estela_M> <https://research.tib.eu/covid-19/entity/Dariolli_Rafael> <https://research.tib.eu/covid-19/entity/Fintelman-Rodrigues_Natalia> <https://research.tib.eu/covid-19/entity/Furtado_Daniel_R> <https://research.tib.eu/covid-19/entity/Gomes_Ismael_C> <https://research.tib.eu/covid-19/entity/Goto-Silva_Livia> <https://research.tib.eu/covid-19/entity/Guimar%C3%A3es_Mar%C3%ADlia_Zaluar_P> <https://research.tib.eu/covid-19/entity/Karmirian_Karina> <https://research.tib.eu/covid-19/entity/Mendes_Mayara_A> <https://research.tib.eu/covid-19/entity/Moreno_L_Souza_Thiago> <https://research.tib.eu/covid-19/entity/Oliveira_Julia_T> <https://research.tib.eu/covid-19/entity/Ornelas_Isis_M> <https://research.tib.eu/covid-19/entity/Pedrosa_Carolina_da_S_G> <https://research.tib.eu/covid-19/entity/Puig-Pijuan_Teresa> <https://research.tib.eu/covid-19/entity/Rehen_Stevens> <https://research.tib.eu/covid-19/entity/Sacramento_Carolina_Q> <https://research.tib.eu/covid-19/entity/Salerno_Jos%C3%A9_A> <https://research.tib.eu/covid-19/entity/Silva_Gomes_Dias_Suelen_da> <https://research.tib.eu/covid-19/entity/Souza_Leticia_R_Q> <https://research.tib.eu/covid-19/entity/Temerozo_Jairo_R> <https://research.tib.eu/covid-19/entity/Torquato_Thayana_C_Q> <https://research.tib.eu/covid-19/entity/Ver%C3%ADssimo_Carla> <https://research.tib.eu/covid-19/entity/Vit%C3%B3ria_Gabriela>
?:doi	<https://research.tib.eu/covid-19/entity/S1873-5061%2821%2900283-X10.1016/j.scr.2021.102436>
?:doi	S1873-5061(21)00283-X10.1016/j.scr.2021.102436
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Research_Support%2C_Non-U.S._Gov%27t>
?:journal	Stem cell research
is ?:pmid of	<https://research.tib.eu/covid-19/entity/34186311>
?:pmid	<https://research.tib.eu/covid-19/entity/34186311>
?:pmid	34186311
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	1.214
?:rankingScore_hIndex	48
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0014038_PROCESS_OF_C0030705> <https://research.tib.eu/covid-19/entity/C0038454_PROCESS_OF_C0030705>
?:title	Non-permissive SARS-CoV-2 infection in human neurospheres.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Property

Value

is ?:annotates of

?:authorAffiliation

[\'D\'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil.\', \'National Institute for Science and Technology on Neuroimmunomodulation (INCT/NIM), Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil; Laboratory on Thymus Research, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.\', \'D\'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil; Institute of Biomedical Sciences, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.\', \'Institute of Biomedical Sciences, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.\', \'Immunopharmacology Laboratory, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil; National Institute for Science and Technology on Innovation in Diseases of Neglected Populations (INCT/IDPN), Center for Technological Development in Health (CDTS), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.\', \'Immunopharmacology Laboratory, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil; Program of Immunology and Inflammation, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.\', \'Immunopharmacology Laboratory, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.\', \'D\'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil; Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.\', \'Pluricell Biotech, São Paulo, SP, Brazil.\', \'Pluricell Biotech, São Paulo, SP, Brazil; Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.\', \'National Institute for Science and Technology on Innovation in Diseases of Neglected Populations (INCT/IDPN), Center for Technological Development in Health (CDTS), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.\', \'D\'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil; Institute of Biomedical Sciences, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil; Institute of Biology, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil. Electronic address: srehen@lance-ufrj.org.\', \'National Institute for Science and Technology on Innovation in Diseases of Neglected Populations (INCT/IDPN), Center for Technological Development in Health (CDTS), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil; Program of Immunology and Inflammation, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil. Electronic address: tmoreno@cdts.fiocruz.br.\', \'D\'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil; Institute of Biomedical Sciences, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil. Electronic address: marilia@lance-ufrj.org.\']

?:citedBy